Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients.
Saalfeld S, Kreher R, Hille G, Niemann U, Hinnerichs M, Öcal O, Schütte K, Zech CJ, Loewe C, van Delden O, Vandecaveye V, Verslype C, Gebauer B, Sengel C, Bargellini I, Iezzi R, Berg T, Klümpen HJ, Benckert J, Gasbarrini A, Amthauer H, Sangro B, Malfertheiner P, Preim B, Ricke J, Seidensticker M, Pech M, Surov A. Saalfeld S, et al. Among authors: zech cj. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):2301-2309. doi: 10.1002/jcsm.13315. Epub 2023 Aug 17. J Cachexia Sarcopenia Muscle. 2023. PMID: 37592827 Free PMC article.
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial.
Surov A, Thormann M, Hinnerichs M, Seidensticker M, Seidensticker R, Öcal O, Schütte K, Zech CJ, Loewe C, van Delden O, Vandecaveye V, Verslype C, Gebauer B, Sengel C, Bargellini I, Iezzi R, Berg T, Klümpen HJ, Benckert J, Gasbarrini A, Amthauer H, Sangro B, Malfertheiner P, Omari J, Wienke A, Ricke J, Pech M. Surov A, et al. Among authors: zech cj. Hepatol Commun. 2023 May 23;7(6):e0165. doi: 10.1097/HC9.0000000000000165. eCollection 2023 Jun 1. Hepatol Commun. 2023. PMID: 37219875 Free PMC article. Clinical Trial.
CT-guided percutaneous marking of small pulmonary nodules with [99mTc]Tc-Macrosalb is very accurate and allows minimally invasive lung-sparing resection: a single-centre quality control.
Doncic N, Zech CJ, Wild D, Bachmann H, Mallaev M, Tsvetkov N, Hojski A, Takes MTL, Lardinois D. Doncic N, et al. Among authors: zech cj. Eur J Nucl Med Mol Imaging. 2023 Aug 31. doi: 10.1007/s00259-023-06410-1. Online ahead of print. Eur J Nucl Med Mol Imaging. 2023. PMID: 37650931
Prognostic value of baseline MRI features in patients treated with thermal ablation for hepatocellular carcinoma.
Öcal O, Schütte K, Malfertheiner P, Berg T, Loewe C, Klümpen HJ, Zech CJ, van Delden O, Ümütlü MR, Deniz S, Khaled NB, De Toni EN, Hoang TPT, Seidensticker R, Aghdassi A, Pech M, Ricke J, Seidensticker M. Öcal O, et al. Among authors: zech cj. Eur J Radiol. 2023 Nov;168:111120. doi: 10.1016/j.ejrad.2023.111120. Epub 2023 Sep 29. Eur J Radiol. 2023. PMID: 37806190
Effect of high-dose glucocorticoid treatment on human brown adipose tissue activity: a randomised, double-blinded, placebo-controlled cross-over trial in healthy men.
Maushart CI, Sun W, Othman A, Ghosh A, Senn JR, Fischer JGW, Madoerin P, Loeliger RC, Benz RM, Takes M, Zech CJ, Chirindel A, Beuschlein F, Reincke M, Wild D, Bieri O, Zamboni N, Wolfrum C, Betz MJ. Maushart CI, et al. Among authors: zech cj. EBioMedicine. 2023 Oct;96:104771. doi: 10.1016/j.ebiom.2023.104771. Epub 2023 Sep 4. EBioMedicine. 2023. PMID: 37659283 Free PMC article. Clinical Trial.
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib.
Öcal O, Schütte K, Zech CJ, Loewe C, van Delden O, Vandecaveye V, Verslype C, Gebauer B, Sengel C, Bargellini I, Iezzi R, Philipp A, Berg T, Klümpen HJ, Benckert J, Pech M, Gasbarrini A, Amthauer H, Bartenstein P, Sangro B, Malfertheiner P, Ricke J, Seidensticker M. Öcal O, et al. Among authors: zech cj. Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4716-4726. doi: 10.1007/s00259-022-05920-8. Epub 2022 Aug 2. Eur J Nucl Med Mol Imaging. 2022. PMID: 35916920 Free PMC article.
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression.
Öcal O, Zech CJ, Fabritius MP, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Berg T, Sengel C, Bargellini I, Iezzi R, Benito A, Pech M, Gasbarrini A, Sangro B, Malfertheiner P, Ricke J, Seidensticker M. Öcal O, et al. Among authors: zech cj. Eur Radiol. 2023 Jan;33(1):493-500. doi: 10.1007/s00330-022-09000-1. Epub 2022 Jul 26. Eur Radiol. 2023. PMID: 35881180 Free PMC article. Clinical Trial.
Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial.
Geyer T, Kazmierczak PM, Steffen IG, Malfertheiner P, Peynircioglu B, Loewe C, Delden OV, Vandecaveye V, Gebauer B, Pech M, Sengel C, Bargellini I, Iezzi R, Benito A, Zech CJ, Gasbarrini A, Schütte K, Ricke J, Seidensticker M. Geyer T, et al. Among authors: zech cj. Biomedicines. 2022 May 18;10(5):1156. doi: 10.3390/biomedicines10051156. Biomedicines. 2022. PMID: 35625900 Free PMC article.
107 results